We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7267:TSEHonda Motor Co., Ltd. Analysis

Data as of 2026-03-10 - not real-time

¥1,466.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Honda Motor (7267.T) trades at a forward P/E of 6.4× versus a trailing P/E of 11.8×, with a price‑to‑book of just 0.46× and a dividend yield of 4.8%, suggesting the stock is materially undervalued relative to its peers. The consensus target price of around ¥1,697 implies a potential upside of roughly 15.7% from the current level of ¥1,466.5. Despite a modest revenue decline of ‑3.4% and thin operating margins (~2.9%), the company generates solid operating cash flow and maintains a payout ratio near 55%, supporting dividend sustainability.
Technically, the share sits below its 20‑day (¥1,544.8), 50‑day (¥1,566.5) and 200‑day (¥1,549.7) moving averages, the RSI is at 39 and the MACD histogram remains negative, indicating short‑term bearish pressure. However, volume is increasing, volatility over the past 30 days is high at 34% but beta is modest (~0.5), tempering market‑wide risk. Combined with a strong dividend and an attractive valuation gap, the stock presents a compelling case for investors willing to weather near‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Technical weakness (price below SMA 20/50/200, bearish MACD)
  • Attractive dividend yield and payout ratio
  • Valuation gap still present but near‑term price pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued fundamentals (low forward P/E, low P/B)
  • Projected earnings upside (forward EPS growth)
  • Sustained dividend income supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term valuation cushion and upside to target price
  • Stable cash flow generation despite high leverage
  • Diversified global footprint reducing single‑market exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin2.33%
P/E Ratio11.8
ROE4.30%
ROA1.29%
Debt/Equity106.01
P/B Ratio0.5
Op. Cash Flow¥816.6B
Free Cash Flow¥39.9B

Technical Analysis

TrendNeutral
RSI39.1
Support¥1,409.50
Resistance¥1,722.00
MA 20¥1,544.75
MA 50¥1,566.51
MA 200¥1,549.73
MACDBearish
VolumeIncreasing
Fear & Greed Index77.57

Valuation

Target Price¥1,697.39
Upside/Downside15.74%
GradeUndervalued
TypeValue
Dividend Yield4.81%

Risk Assessment

Beta0.54
Volatility33.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.